Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis

被引:109
作者
Nemeth, Zoltan H.
Csoka, Balazs
Wilmanski, Jeanette
Xu, DaZhong
Lu, Qi
Ledent, Catherine
Deitch, Edwin A.
Pacher, Pal
Spolarics, Zoltan
Hasko, Gyorgy
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA
[2] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Nucl, Brussels, Belgium
[3] NIAAA, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.176.9.5616
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanisms governing the impairment of bacterial clearance and immune function in sepsis are not known. Adenosine levels are elevated during tissue hypoxia and damage associated with sepsis. Adenosine has strong immunosuppressive effects, many of which are mediated by A(2A) receptors (A(2A)R) expressed on immune cells. We examined whether A(2A)R are involved in the regulation of immune function in cecal ligation and puncture-induced murine polymicrobial sepsis by genetically or pharmacologically inactivating A(2A)R. A(2A)R knockout (KO) mice were protected from the lethal effect of sepsis and had improved bacterial clearance compared with wild-type animals. cDNA microarray analysis and flow cytometry revealed increased MHC II expression in A(2A)-inactivated mice, suggesting improved Ag presentation as a mechanism of protection. Apoptosis was attenuated in the spleen of A(2A) KO mice indicating preserved lymphocyte function. Levels of the immunosuppressive cytokines IL-10 and IL-6 were markedly lower following A(2A)R blockade. Similar to observations with A(2A)R KO mice, an A(2A)R antagonist increased survival, even when administered in a delayed fashion. These studies demonstrate that A(2A)R blockade may be useful in the treatment of infection and sepsis.
引用
收藏
页码:5616 / 5626
页数:11
相关论文
共 73 条
[1]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[2]  
Apasov S, 2000, BLOOD, V95, P3859
[3]   Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes:: studies of cells from A2A-receptor-gene-deficient mice [J].
Armstrong, JM ;
Chen, JF ;
Schwarzschild, MA ;
Apasov, S ;
Smith, PT ;
Caldwell, C ;
Chen, P ;
Figler, H ;
Sullivan, G ;
Fink, S ;
Linden, J ;
Sitkovsky, M .
BIOCHEMICAL JOURNAL, 2001, 354 :123-130
[4]   Differential induction of apoptosis in lymphoid tissues during sepsis: Variation in onset, frequency, and the nature of the mediators [J].
Ayala, A ;
Herdon, CD ;
Lehman, DL ;
Ayala, CA ;
Chaudry, IH .
BLOOD, 1996, 87 (10) :4261-4275
[5]   The chronic consequences of severe sepsis [J].
Benjamin, CF ;
Hogaboam, CM ;
Kunkel, SL .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (03) :408-412
[6]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[7]   Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice [J].
Blackburn, MR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) :66-70
[8]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE [J].
BONE, RC ;
SPRUNG, CL ;
SIBBALD, WJ .
CRITICAL CARE MEDICINE, 1992, 20 (06) :724-726
[9]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[10]   HIGH CIRCULATING LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH SEPTIC SHOCK - EVOLUTION DURING SEPSIS, PROGNOSTIC VALUE, AND INTERPLAY WITH OTHER CYTOKINES [J].
CALANDRA, T ;
GERAIN, J ;
HEUMANN, D ;
BAUMGARTNER, JD ;
GLAUSER, MP .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (01) :23-29